Illustrate Rxpassport with Risk Factor Of Colorectal Cancer
Article Related to Risk Factor Of Colorectal Cancer :
Diagnose Colorectal Cancer or Colon Cancer – risk factor of colorectal cancer
Colorectal cancer, also known as CRC or colon cancer, is one of the leading cancers causing deaths in the U.S ., striking both men and women similarly. Outperforming both prostate cancer and breast cancer in mortality rates, colon cancer is second to lung cancer in causing death. With approximately 150,000 new cases diagnosed per year and nearly 60,000 deaths a year, the impressive actuality is that colon cancer is awfully preventable. The actuality is that when colon cancer is detected early, with medicine, the 5-year survival rates is more than 90%. This is why colon cancer screening is crucial to prevent and rapidly detect this deadly disease.
Colon Cancer Screening
The American Cancer Society recommends that both men and women should adopt one of the following 5 colon cancer screening recommendations, even if they are only at median probability for developing colon cancer.
* A yearly fecal magical blood evaluation, too announced FOBT, or a fecal immunochemical assessment, too announced FIT
* A adaptable sigmoidoscopy research every 5 years
* A yearly fecal magical blood exam( FOBT) or fecal immunochemical exam( FIT) including a resilient sigmoidoscopy every 5 years
* A doubled oppose barium enema every 5 years
* A colonoscopy every 10 years
The most preferred option of all of these colon cancer screening recommendations is# 3: a yearly fecal magical blood research( FOBT) or fecal immunochemical test( FIT) including a adaptable sigmoidoscopy every five years. The American Cancer Society also recommends that all colon cancer screening exams with positive results be immediately followed by a colonoscopy.
A New Home Colon Cancer Screening Kit
One of the most exciting the development in colon cancer screening is the development of a new residence research announced Quidel’s QuickVue iFOB Test. This easy test is a type of fecal immunochemical exam( FIT) that individual patients use at home. In the privacy of home, individual patients musters a sample, accomplishes the contents of the equipment, and forwards a test to a specified specialist or laboratory for experimenting. This simple home colon cancer screening research detects any blood in the test, which indicates the problem of gastrointestinal disorders like colon cancer.
Requiring exclusively one specimen, the Quidel QuickVue iFOB Test sees human blood, or hemoglobin. Cases do not need to follow any dietary rules, however, there are a few regulations involving prescriptions. This discriminates this home colon cancer screening exam from guaiac located assessments with arduous restrictions. The American Cancer Society recommends the Quidel QuickVue iFOB Test because it is patient friendly, developing in more beings taking the test than with guaiac or FOBT evaluations. When the colon cancer screening process is simple, the hope is that more patients will take the test.
Unfortunately, even with the advancements in colon cancer screening, fewer than 50% of people over the age of 50 make the test on the recommended basis. Many people over this age “ve never” even made a colon cancer screening evaluation. Education is the answer. If people knew that it could make 10 times for cancerous cadres to take over, they would realize that early sensing through a colon cancer screening is an easy and painless practice to save “peoples lives”